Effectiveness of the Fiocruz recombinant ChadOx1-nCoV19 against variants of SARS-CoV-2 in the Municipality of Botucatu-SPArticle Published on 2022-10-132022-11-16 Journal: Frontiers in Public Health [Category] COVID19(2023년), SARS, 변종, [키워드] “real world” study. Analysis Brazil calculated ChAdOx1 clinical trial comparable Control Coverage COVID-19 COVID-19 disease COVID-19 pandemic death Delta delta variant demographics dose Effectiveness Efficacy eligible first dose Gamma Hospitalization individual initiated Lineage material municipality offered PCR test PCR tests positive raise reduced reported sequenced severe disease severity state Strains Study design symptomatic infection Symptoms unique vaccinated individual vaccinated individuals vaccination Vaccine vaccine dose Vaccines variant variants of concern variants of SARS-CoV-2 [DOI] 10.3389/fpubh.2022.1016402 PMC 바로가기
Arylcoumarin perturbs SARS-CoV-2 pathogenesis by targeting the S-protein/ACE2 interactionArticle Published on 2022-10-112022-11-16 Journal: Scientific Reports [Category] COVID19(2023년), SARS, 변종, [키워드] ACE2 adaptive Analysis antibody binding affinity binding site convalescent coumarin COVID-19 D614G death derivative develop docking drug human Angiotensin-converting enzyme human host in vitro in vivo Infection inhibitor inhibitors Interaction lack molecular molecular docking analysis Mutation N501Y new SARS-CoV-2 NF1 oxygen protein complex protocol rapid increase receptor Reinfection required S-protein SARS-CoV-2 SARS-CoV-2 pathogenesis SARS-CoV-2 spike glycoprotein second wave Spike proteins Treatment vaccinated individuals vaccination variant variants viral genome [DOI] 10.1038/s41598-022-20759-7 PMC 바로가기
A bivalent SARS-CoV-2 monoclonal antibody combination does not affect the immunogenicity of a vector-based COVID-19 vaccine in macaquesArticle Published on 2022-10-052022-11-15 Journal: Science Translational Medicine [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] acute respiratory syndrome Adenovirus Administered administration Affect approach cellular immunity coronavirus coronavirus disease COVID-19 COVID-19 vaccine cynomolgus macaques evaluate Human humoral mAb mAbs macaque monoclonal antibody monoclonal antibody combination not affect offer required SARS-CoV-2 SARS-CoV-2 vaccine SARS-CoV-2 vaccines SARS-CoV-2 variant spike glycoprotein the vaccine Treatment vaccinated individuals vaccination rates Vaccine viral vector-based waning immunity [DOI] 10.1126/scitranslmed.abo6160 PMC 바로가기
COVID-19-Associated Hospitalizations Among Vaccinated and Unvaccinated Adults 18 Years or Older in 13 US States, January 2021 to April 2022Article Published on 2022-10-012022-11-16 Journal: JAMA Internal Medicine [Category] COVID19(2023년), SARS, 변종, [키워드] adults hospitalized age association booster dose calculated Care Characteristics clinician Coverage COVID-19 COVID-19 vaccine Critical cross-sectional defined determine dose effort eligible Factor hospital Hospitalization Hospitalized hospitalized patient immunization information laboratory-confirmed SARS-CoV-2 infection lowest median medical condition network Older omicron outcome Patient percentage positive Practitioner predominant promote public health ranged risk factor SARS-CoV-2 test state table understanding vaccinated individuals vaccination variant were assessed were used with COVID-19 Year [DOI] 10.1001/jamainternmed.2022.4299 PMC 바로가기
Rapid and quantitative detection of multiple antibodies against SARS-CoV-2 mutant proteins by photo-immobilized microarrayArticle Published on 2022-10-012022-11-15 Journal: Analytical sciences : the international journal of the Japan Society for [Category] COVID19(2023년), SARS, 변종, 진단, 치료기술, [키워드] antibody Antibody assays Antibody detection aqueous solution automatically Blood blood test coated collected condition correlated COVID-19 Diagnosis diagnostic facilitate IgG Immune status immunoassay immunochromatography increase in individual Infection Microarray microarray. mutant mutant protein mutant virus Mutation Polymer polymers produced Protein Quantitative Rapid SARS-CoV-2 sera serum the patient vaccinated individuals viral infectious disease virus [DOI] 10.1007/s44211-022-00161-z PMC 바로가기
Evaluation of a rapid semiquantitative lateral flow assay for the prediction of serum neutralizing activity against SARS-CoV-2 variantsArticle Published on 2022-10-012022-11-15 Journal: Journal of Clinical Virology [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] anti-SARS-CoV-2 anti-SARS-CoV-2 IgG antibody Cohort collected correlated correlation COVID-19 COVID-19 recovered patient cut-offs Delta IgG level Immunity immunization individual Infection Lateral lateral flow lateral flow assay NAb NAbs neutralization Neutralizing activity Neutralizing antibodies omicron Patient Post-infection predicted provided SARS-CoV-2 SARS-CoV-2 variant SARS-CoV-2 variants sera serum serum sample shown significant level simple the vaccine vaccinated individuals variant variants variants. [DOI] 10.1016/j.jcv.2022.105268 PMC 바로가기
Temperature Influences the Interaction between SARS-CoV-2 Spike from Omicron Subvariants and Human ACE2Article Published on 2022-09-302022-11-16 Journal: Viruses [Category] SARS, 변종, [키워드] ACE2 ACE2 affinity ACE2 receptor Affect arising BA.4 BA.5 COVID-19 domain enzyme glycoprotein Human immunogenic include infect influence Interaction multiple mutation mutated omicron other variants plasma RBD receptor SARS-CoV-2 shown significantly increased spike spike glycoprotein temperature the Spike translate Transmission vaccinated individuals variant Variant of concern. Viral transmission VoC [DOI] 10.3390/v14102178 PMC 바로가기
Household transmission of SARS-CoV-2 Omicron variant of concern subvariants BA.1 and BA.2 in DenmarkArticle Published on 2022-09-302022-11-16 Journal: Nature Communications [Category] SARS, 변종, [키워드] Breakthrough infection Contact Denmark Follow-up household household contact Infection omicron protective effect Ratio reduce SAR SARS Coronavirus SARS-CoV-2 secondary attack rate Secondary infection susceptibility Transmission dynamics transmission of SARS-CoV-2 vaccinated individuals vaccination variant [DOI] 10.1038/s41467-022-33498-0 PMC 바로가기
Baculovirus-Free SARS-CoV-2 Virus-like Particle Production in Insect Cells for Rapid Neutralization AssessmentArticle Published on 2022-09-202022-11-15 Journal: Viruses [Category] SARS, 진단, [키워드] ACE2 Analysis antibodies antibody approach assays assessment binding candidate Cell cellular cellular assay donors enzyme evaluate expression expression plasmid expression vector flow cytometric fluorescent fusion genomic information GFP insect insect cell insect cells labeling membrane membrane protein monoclonal antibody NTA Particle plasmid transfection Production purification quantification Rapid required SARS-CoV-2 SARS-CoV-2 envelope secondary antibody sera Spike protein TEM therapeutic transmission electron microscopy vaccinated individuals virus Virus-like particle Virus-like particles (VLPs). VLP VLPs [DOI] 10.3390/v14102087 PMC 바로가기
Vaccination Decreases the Infectious Viral Load of Delta Variant SARS-CoV-2 in Asymptomatic PatientsArticle Published on 2022-09-182022-11-15 Journal: Viruses [Category] SARS, 변종, 진단, [키워드] affecting Anti-spike asymptomatic infection asymptomatic infections B.1.617.2 breakthrough Breakthrough infection caused collected COVID-19 decrease Delta delta variant IgA individual Infectious virus load nasal Nasopharyngeal swab nasopharyngeal swabs other variants patients quantified risk SARS-CoV-2 secretion significantly higher Symptomatic patients Transmission vaccinated individuals vaccination vaccination. Vaccine vaccinee Viral load Viral RNA viral RNA genome while [DOI] 10.3390/v14092071 PMC 바로가기